Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast
- 31 March 2001
- journal article
- clinical trial
- Published by Elsevier BV in Respiratory Medicine
- Vol. 95 (3), 227-234
- https://doi.org/10.1053/rmed.2000.1027
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthmaJournal of Allergy and Clinical Immunology, 2000
- Explaining Drug Spending Trends: Does Perception Match Reality?Health Affairs, 2000
- Montelukast Added to Inhaled Beclomethasone in Treatment of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic AsthmaAnnals of Internal Medicine, 1999
- First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthmaThorax, 1998
- Increased use of inhaled corticosteroids and reduced hospitalizations in adult asthmatics: 11 years' experience in a Japanese hospitalRespirology, 1998
- Outcomes and cost benefits associated with the introduction of inhaled corticosteroid therapy in a medicaid population of asthmatic patientsClinical Therapeutics, 1998
- A National Estimate of the Economic Costs of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1997
- An Economic Evaluation of Asthma in the United StatesThe New England Journal of Medicine, 1992
- National Trends in the Morbidity and Mortality of Asthma in the USSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1987